A Randomized Placebo-Controlled Dose-Response Trial of Muvz™ for Knee and Low-Back Support in Physically Active Adults
The study finds E-PR-01 effective for improving overall joint health, with the higher dose showing greater efficacy. These findings align with the earlier studies of E-PR-01 for knee and low back discomfort.
Authors
- Sagar Karvir
- Ajinkya Desale
- Shalini Srivastava (ORCID: https://orcid.org/0000-0001-8497-5929)
- Surendra Bhasale
- Douglas Kalman (ORCID: https://orcid.org/0000-0003-0882-9748)
- Kshitij Shah
- Manish Chatte (ORCID: https://orcid.org/0000-0001-5332-7523)
- Rohit Nalavade
Institutions
- Nova Southeastern University (US)
- Axis Multispecialty Hospital (IN)
- Vedic Lifesciences (India) (IN)
- Sparsh Hospital (IN)
- Pain Clinic of India (IN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/dddt.s486836
- Primary Topic
- Musculoskeletal pain and rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00